Clinical trial
The Role of m6A RNA Modification in Moyamoya Disease
NCT04696094 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of m6A RNA Modification in Moyamoya Disease
- Lead sponsor
- Beijing Tiantan Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2021
- Completion date
- December 31, 2022
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.